From: GAP43, a novel metastasis promoter in non-small cell lung cancer
Factorsa | HR | 95% CI | P value |
---|---|---|---|
Univariate analysis | |||
 BMI1 | 0.58 | 0.29–1.16 | 0.124 |
 POU5F1 | 0.75 | 0.38–1.47 | 0.397 |
 KLF4 | 1.11 | 0.57–2.18 | 0.757 |
 SMO | 0.86 | 0.43–1.68 | 0.650 |
 JAG1 | 0.85 | 0.43–1.67 | 0.634 |
 SPARC | 1.44 | 0.73–2.84 | 0.292 |
 ST6GALNAC5 | 1.90 | 0.95–3.81 | 0.071 |
 SNAI1 | 1.89 | 0.96–3.74 | 0.066 |
 TNF | 1.23 | 0.63–2.41 | 0.545 |
 CXCR5 | 0.77 | 0.39–1.51 | 0.448 |
 GFAP | 1.00 | 0.51–1.96 | 0.995 |
 DYNC1LI2 | 1.13 | 0.58–2.21 | 0.729 |
 MMP3 | 1.21 | 0.62–2.37 | 0.579 |
 CDH2 | 1.87 | 0.94–3.71 | 0.073 |
 EGFR | 0.65 | 0.33–1.28 | 0.212 |
 VCAN | 1.50 | 0.76–2.97 | 0.247 |
 HGF | 0.76 | 0.39–1.50 | 0.427 |
 CTNNB1 | 0.76 | 0.39–1.50 | 0.428 |
 CXCR4 | 1.46 | 0.74–2.88 | 0.275 |
 KIF3A | 1.47 | 0.74–2.89 | 0.269 |
 GPM6A | 0.70 | 0.36–1.38 | 0.307 |
 HBEGF | 0.95 | 0.48–1.86 | 0.869 |
 CXCL13 | 0.99 | 0.51–1.95 | 0.985 |
 TGFB2 | 0.92 | 0.47–1.80 | 0.803 |
 PLP1 | 0.81 | 0.39–1.69 | 0.568 |
 TWIST1 | 1.45 | 0.74–2.86 | 0.280 |
 PTGS2 | 0.87 | 0.44–1.71 | 0.679 |
 BPTF | 0.77 | 0.39–1.52 | 0.443 |
 FABP7 | 1.92 | 0.96–3.83 | 0.066 |
 GAP43 | 2.12 | 1.09–4.13 | 0.027 |
 PMP2 | 2.12 | 1.05–4.30 | 0.036 |
 UGT8 | 1.23 | 0.63–2.41 | 0.549 |
 GPM6B | 1.00 | 0.51–1.96 | 0.990 |
 FAM107A | 0.62 | 0.31–1.23 | 0.169 |
 IL8 | 1.27 | 0.65–2.49 | 0.492 |
 MMP9 | 1.16 | 0.59–2.27 | 0.668 |
Multivariate analysisb | |||
 GAP43 | 3.29 | 1.55–7.00 | 0.002 |
 SNAI1 | 1.98 | 1.00–3.95 | 0.051 |
 Grade | 2.08 | 1.00–4.34 | 0.051 |